// App-Quantinova.ai

4121 : Chaperonin containing-TCP-1 protein level in breast cancer cells predicts therapeutic application of a cytotoxic peptide

Researchers

Presenter

  • Annette R. Khaled

Principal Investigators

  • Amr S. Khaled

  • Rania Bassiouni

  • Priya Vishnubhotla

Medical Centers

  • University of Central Florida, Orlando, FL

  • VA Medical Center, Orlando, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Catalase

  • Progesterone receptor

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A